Qualigen Therapeutics, Inc. (QLGN)
NASDAQ: QLGN · IEX Real-Time Price · USD
0.400
-0.004 (-0.99%)
At close: Mar 28, 2024, 3:56 PM
0.410
+0.009 (2.37%)
After-hours: Mar 28, 2024, 4:31 PM EDT

Qualigen Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Year 2022202120192019201820172016201520142013
Net Income
-18.64-17.9-1.79-10.13-19.41-10.97-18.38-9.18-3.07-2.64
Depreciation & Amortization
0.380.340.220.110.010.010.01000
Share-Based Compensation
5.485.290.010.440.650.91.362.890.710.01
Other Operating Activities
-0.47-2.471.62-4.932.88-0.441.810.170.610.12
Operating Cash Flow
-13.25-14.730.06-14.52-13.33-7.4-15.21-5.72-1.16-1.96
Capital Expenditures
-0.32-0.13-0.01-0-0-0.01-0.01-0.02-0-0.01
Acquisitions
0.14000000000
Change in Investments
0007-6.9700000
Other Investing Activities
--0.01-0.19-------
Investing Cash Flow
-0.18-0.14-0.197-6.97-0.01-0.01-0.02-0-0.01
Share Issuance / Repurchase
-08.8201.41-025.037.0421.010.010
Debt Issued / Paid
2.9-0.140.17000000.57-0.01
Other Financing Activities
0.01-0.25--5.49-2.04-0.6-2.192.870.65
Financing Cash Flow
2.918.430.171.415.4822.996.4418.813.460.64
Exchange Rate Effect
0.02000000000
Net Cash Flow
-10.52-6.440.03-6.11-14.8215.59-8.7713.072.3-1.32
Free Cash Flow
-13.57-14.870.05-14.52-13.33-7.41-15.22-5.74-1.16-1.97
Free Cash Flow Margin
-272.23%-262.93%0.91%-------
Free Cash Flow Per Share
-3.53-5.070.09-379.26-628.45-835.86-4230.02-4868.48-6400.69-10886.23
Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).